{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T07:52:59Z","timestamp":1768463579414,"version":"3.49.0"},"reference-count":110,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/T016736\/1"],"award-info":[{"award-number":["MR\/T016736\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012041","name":"Versus Arthritis","doi-asserted-by":"publisher","award":["20 089"],"award-info":[{"award-number":["20 089"]}],"id":[{"id":"10.13039\/501100012041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012041","name":"Versus Arthritis","doi-asserted-by":"publisher","award":["21 753"],"award-info":[{"award-number":["21 753"]}],"id":[{"id":"10.13039\/501100012041","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Immunology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.smim.2021.101547","type":"journal-article","created":{"date-parts":[[2021,12,4]],"date-time":"2021-12-04T07:48:49Z","timestamp":1638604129000},"page":"101547","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Cellular and molecular diversity in Sjogren\u2019s syndrome salivary glands: Towards a better definition of disease subsets"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0439-0344","authenticated-orcid":false,"given":"Elena","family":"Pontarini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2490-0199","authenticated-orcid":false,"given":"Rachel","family":"Coleby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3878-5216","authenticated-orcid":false,"given":"Michele","family":"Bombardieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.smim.2021.101547_bib0005","doi-asserted-by":"crossref","first-page":"16047","DOI":"10.1038\/nrdp.2016.47","article-title":"Sjogren syndrome","volume":"2","author":"Brito-Zeron","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.smim.2021.101547_bib0010","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3109\/03009742.2014.931457","article-title":"Incident cases of primary Sjogren\u2019s syndrome during a 5-year period in Stockholm County: a descriptive study of the patients and their characteristics","volume":"44","author":"Kvarnstrom","year":"2015","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.smim.2021.101547_bib0015","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1136\/annrheumdis-2014-205375","article-title":"Epidemiology of primary Sjogren\u2019s syndrome: a systematic review and meta-analysis","volume":"74","author":"Qin","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.smim.2021.101547_bib0020","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/rheumatology\/key392","article-title":"Is early-onset primary Sjogren\u2019s syndrome a worse prognosis form of the disease?","volume":"58","author":"Anquetil","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.smim.2021.101547_bib0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","article-title":"2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sjogren's syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"76","author":"Shiboski","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.smim.2021.101547_bib0030","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0140-6736(05)66990-5","article-title":"Sjogren\u2019s syndrome","volume":"366","author":"Fox","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.smim.2021.101547_bib0035","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1136\/ard.2009.110619","article-title":"EULAR Sjogren\u2019s syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren\u2019s syndrome","volume":"69","author":"Seror","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.smim.2021.101547_bib0040","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1136\/annrheumdis-2013-204653","article-title":"Abatacept treatment reduces disease activity in early primary Sjogren\u2019s syndrome (open-label proof of concept ASAP study)","volume":"73","author":"Meiners","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.smim.2021.101547_bib0045","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/rheumatology\/ket349","article-title":"Systemic involvement in primary Sjogren\u2019s syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 Spanish patients (GEAS-SS Registry)","volume":"53","author":"Ramos-Casals","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl 126","key":"10.1016\/j.smim.2021.101547_bib0050","first-page":"283","article-title":"Ten years of the ESSDAI: is it fit for purpose?","volume":"38","author":"de Wolff","year":"2020","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.smim.2021.101547_bib0055","first-page":"9","article-title":"Composite of Relevant Endpoints for Sj\u00f6gren\u2019s Syndrome (CRESS): development and validation of a novel outcome measure","volume":"3","author":"Arends","year":"2021","journal-title":"Lancet Rheumatol."},{"key":"10.1016\/j.smim.2021.101547_bib0060","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3389\/fmed.2018.00102","article-title":"Lymphoma and lymphomagenesis in primary Sjogren\u2019s syndrome","volume":"5","author":"Alunno","year":"2018","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.smim.2021.101547_bib0065","article-title":"Lymphomas complicating primary Sjogren\u2019s syndrome: from autoimmunity to lymphoma","author":"Nocturne","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.smim.2021.101547_bib0070","doi-asserted-by":"crossref","first-page":"50098","DOI":"10.18632\/oncotarget.15100","article-title":"Predictable biomarkers of developing lymphoma in patients with Sjogren syndrome: a nationwide population-based cohort study","volume":"8","author":"Chiu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.smim.2021.101547_bib0075","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1182\/blood-2006-06-030494","article-title":"MALT lymphoma and extranodal diffuse large B-cell lymphoma are targeted by aberrant somatic hypermutation","volume":"109","author":"Deutsch","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.smim.2021.101547_bib0080","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1002\/art.11286","article-title":"Extrasalivary lymphoma development in Sjogren\u2019s syndrome: clonal evolution from parotid gland lymphoproliferation and role of local triggering","volume":"48","author":"Gasparotto","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.smim.2021.101547_bib0085","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.3389\/fimmu.2020.01486","article-title":"Repertoire analysis of B-Cells located in striated ducts of salivary glands of patients with Sjogren\u2019s syndrome","volume":"11","author":"Visser","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2021.101547_bib0090","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1084\/jem.20050068","article-title":"Among B cell non-Hodgkin\u2019s lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity","volume":"201","author":"Bende","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.smim.2021.101547_bib0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.102316","article-title":"Predictive markers of lymphomagenesis in Sjogren\u2019s syndrome: From clinical data to molecular stratification","volume":"104","author":"Kapsogeorgou","year":"2019","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.smim.2021.101547_bib0100","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jaut.2013.10.002","article-title":"Biomarkers of lymphoma in Sjogren\u2019s syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study","volume":"51","author":"Quartuccio","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.smim.2021.101547_bib0105","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/ard.2005.041186","article-title":"Lymphoma and other malignancies in primary Sjogren\u2019s syndrome: a cohort study on cancer incidence and lymphoma predictors","volume":"65","author":"Theander","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.smim.2021.101547_bib0110","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/art.39518","article-title":"Rheumatoid factor and disease activity are independent predictors of lymphoma in primary Sjogren\u2019s syndrome","volume":"68","author":"Nocturne","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.smim.2021.101547_bib0115","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/MD.0b013e3181b76ab5","article-title":"Hematologic manifestations and predictors of lymphoma development in primary Sjogren syndrome: clinical and pathophysiologic aspects","volume":"88","author":"Baimpa","year":"2009","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.smim.2021.101547_bib0120","doi-asserted-by":"crossref","first-page":"e3766","DOI":"10.1097\/MD.0000000000003766","article-title":"Predicting the risk for lymphoma development in Sjogren syndrome: An easy tool for clinical use","volume":"95","author":"Fragkioudaki","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.smim.2021.101547_bib0125","first-page":"10","article-title":"Symptom-based stratification of patients with primary Sj\u00f6gren\u2019s syndrome: multi-dimensional characterisation of international observational cohorts and reanalyses of randomised clinical trials","volume":"1","author":"Tarn","year":"2019","journal-title":"Lancet Rheumatol."},{"key":"10.1016\/j.smim.2021.101547_bib0130","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/art.40093","article-title":"Randomized controlled trial of rituximab and cost-effectiveness analysis in treating fatigue and oral dryness in primary Sjogren\u2019s syndrome","volume":"69","author":"Bowman","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.smim.2021.101547_bib0135","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1136\/jcp.21.5.656","article-title":"Labial salivary gland biopsy in Sjogren\u2019s disease","volume":"21","author":"Chisholm","year":"1968","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.smim.2021.101547_bib0140","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0030-4220(74)90417-4","article-title":"The histopathology of Sjogren\u2019s syndrome in labial salivary gland biopsies","volume":"37","author":"Greenspan","year":"1974","journal-title":"Oral Surg. Oral Med. Oral Pathol."},{"issue":"Suppl 112","key":"10.1016\/j.smim.2021.101547_bib0145","first-page":"222","article-title":"The role of salivary gland histopathology in primary Sjogren\u2019s syndrome: promises and pitfalls","volume":"36","author":"Kroese","year":"2018","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.smim.2021.101547_bib0150","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nrrheum.2016.217","article-title":"Ectopic lymphoid neogenesis in rheumatic autoimmune diseases","volume":"13","author":"Bombardieri","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.smim.2021.101547_bib0155","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nri3700","article-title":"Ectopic lymphoid-like structures in infection, cancer and autoimmunity","volume":"14","author":"Pitzalis","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.smim.2021.101547_bib0160","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nri1054","article-title":"Organogenesis of lymphoid tissues","volume":"3","author":"Mebius","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.smim.2021.101547_bib0165","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/mi.2014.11","article-title":"The development and function of mucosal lymphoid tissues: a balancing act with micro-organisms","volume":"7","author":"Randall","year":"2014","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.smim.2021.101547_bib0170","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nri2832","article-title":"New insights into the development of lymphoid tissues","volume":"10","author":"van de Pavert","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.smim.2021.101547_bib0175","doi-asserted-by":"crossref","first-page":"11024","DOI":"10.1073\/pnas.1503315112","article-title":"IL-22 regulates lymphoid chemokine production and assembly of tertiary lymphoid organs","volume":"112","author":"Barone","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.smim.2021.101547_bib0180","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/ard.2011.154013","article-title":"Potential involvement of IL-22 and IL-22-producing cells in the inflamed salivary glands of patients with Sjogren\u2019s syndrome","volume":"71","author":"Ciccia","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.smim.2021.101547_bib0185","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/art.41289","article-title":"Impaired interleukin-27-mediated control of CD4+ t cell function impact on ectopic lymphoid structure formation in patients with Sjogren\u2019s syndrome","volume":"72","author":"Lucchesi","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.smim.2021.101547_bib0190","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1002\/art.21062","article-title":"Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjogren\u2019s syndrome","volume":"52","author":"Barone","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.smim.2021.101547_bib0195","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.4049\/jimmunol.180.7.5130","article-title":"CXCL13, CCL21, and CXCL12 expression in salivary glands of patients with Sjogren\u2019s syndrome and MALT lymphoma: association with reactive and malignant areas of lymphoid organization","volume":"180","author":"Barone","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2021.101547_bib0200","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1002\/art.11311","article-title":"Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjogren\u2019s syndrome","volume":"48","author":"Salomonsson","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.smim.2021.101547_bib0205","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1002\/1529-0131(200111)44:11<2633::AID-ART443>3.0.CO;2-9","article-title":"Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjogren\u2019s syndrome","volume":"44","author":"Amft","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.smim.2021.101547_bib0210","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/1529-0131(200102)44:2<408::AID-ANR60>3.0.CO;2-0","article-title":"\"Lymphoid\" chemokine messenger RNA expression by epithelial cells in the chronic inflammatory lesion of the salivary glands of Sjogren\u2019s syndrome patients: possible participation in lymphoid structure formation","volume":"44","author":"Xanthou","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.smim.2021.101547_bib0215","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.705079","article-title":"Serum, but not saliva, CXCL13 levels associate with infiltrating CXCL13+ cells in the minor salivary gland lesions and other histologic parameters in patients with Sjogren\u2019s syndrome","volume":"12","author":"Chatzis","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2021.101547_bib0220","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/rheumatology\/kez255","article-title":"CXCL13 as biomarker for histological involvement in Sjogren\u2019s syndrome","volume":"59","author":"Colafrancesco","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.smim.2021.101547_bib0225","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1002\/art.39315","article-title":"CXCL13 and CCL11 serum levels and lymphoma and disease activity in primary Sjogren\u2019s syndrome","volume":"67","author":"Nocturne","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.smim.2021.101547_bib0230","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1172\/JCI3234","article-title":"Antigen-driven clonal proliferation of B cells within the target tissue of an autoimmune disease. The salivary glands of patients with Sjogren\u2019s syndrome","volume":"102","author":"Stott","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.smim.2021.101547_bib0235","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1002\/art.38726","article-title":"Implication of Epstein-Barr virus infection in disease-specific autoreactive B cell activation in ectopic lymphoid structures of Sjogren\u2019s syndrome","volume":"66","author":"Croia","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.smim.2021.101547_bib0240","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.4049\/jimmunol.0803588","article-title":"Ectopic germinal centers are rare in Sjogren\u2019s syndrome salivary glands and do not exclude autoreactive B cells","volume":"182","author":"Le Pottier","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2021.101547_bib0245","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.686457","article-title":"Association between minor salivary gland biopsy during Sjgren\u2019s syndrome and serologic biomarkers: a systematic review and meta-analysis","volume":"12","author":"Berardicurti","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2021.101547_bib0250","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.semarthrit.2012.07.003","article-title":"The role of ectopic germinal centers in the immunopathology of primary Sjogren\u2019s syndrome: a systematic review","volume":"42","author":"Risselada","year":"2013","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.smim.2021.101547_bib0255","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1126\/science.1175870","article-title":"Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation","volume":"325","author":"Johnston","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.smim.2021.101547_bib0260","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.immuni.2008.05.009","article-title":"Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages","volume":"29","author":"Nurieva","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2021.101547_bib0265","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.immuni.2009.07.002","article-title":"The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment","volume":"31","author":"Yu","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2021.101547_bib0270","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev-immunol-031210-101400","article-title":"Follicular helper CD4 t cells (TFH)","volume":"29","author":"Crotty","year":"2011","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.smim.2021.101547_bib0275","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.immuni.2011.03.023","article-title":"ICOS receptor instructs T follicular helper cell versus effector cell differentiation via induction of the transcriptional repressor Bcl6","volume":"34","author":"Choi","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2021.101547_bib0280","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.4049\/jimmunol.1302617","article-title":"B cells in T follicular helper cell development and function: separable roles in delivery of ICOS ligand and antigen","volume":"192","author":"Weinstein","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2021.101547_bib0285","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/imr.12411","article-title":"T follicular regulatory cells","volume":"271","author":"Sage","year":"2016","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.smim.2021.101547_bib0290","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/rheumatology\/kez268","article-title":"Epigenetically quantified immune cells in salivary glands of Sjogren\u2019s syndrome patients: a novel tool that detects robust correlations of T follicular helper cells with immunopathology","volume":"59","author":"Blokland","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.smim.2021.101547_bib0295","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1136\/annrheumdis-2020-217646","article-title":"Unique expansion of IL-21+ Tfh and Tph cells under control of ICOS identifies Sjogren\u2019s syndrome with ectopic germinal centres and MALT lymphoma","volume":"79","author":"Pontarini","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.smim.2021.101547_bib0300","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature20810","article-title":"Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis","volume":"542","author":"Rao","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.smim.2021.101547_bib0305","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jaut.2013.11.003","article-title":"Differentiation of follicular helper T cells by salivary gland epithelial cells in primary Sjogren\u2019s syndrome","volume":"51","author":"Gong","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.smim.2021.101547_bib0310","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/art.40424","article-title":"The ratio of blood T follicular regulatory cells to t follicular helper cells marks ectopic lymphoid structure formation while activated follicular helper t cells indicate disease activity in primary Sjogren\u2019s syndrome","volume":"70","author":"Fonseca","year":"2018","journal-title":"Arthritis Rheumatol."},{"issue":"Suppl 126","key":"10.1016\/j.smim.2021.101547_bib0315","first-page":"222","article-title":"Blocking T cell co-stimulation in primary Sjogren\u2019s syndrome: rationale, clinical efficacy and modulation of peripheral and salivary gland biomarkers","volume":"38","author":"Pontarini","year":"2020","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.smim.2021.101547_bib0320","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.639975","article-title":"The imbalance of circulating follicular t helper cell subsets in primary Sjogren\u2019s syndrome associates with serological alterations and abnormal B-Cell distribution","volume":"12","author":"Szabo","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2021.101547_bib0325","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.4049\/jimmunol.179.7.4929","article-title":"Activation-induced cytidine deaminase expression in follicular dendritic cell networks and interfollicular large B cells supports functionality of ectopic lymphoid neogenesis in autoimmune sialoadenitis and MALT lymphoma in Sjogren\u2019s syndrome","volume":"179","author":"Bombardieri","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2021.101547_bib0330","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.semarthrit.2014.05.015","article-title":"Is minor salivary gland biopsy more than a diagnostic tool in primary Sjogrens syndrome? Association between clinical, histopathological, and molecular features: a retrospective study","volume":"44","author":"Carubbi","year":"2014","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.smim.2021.101547_bib0335","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/ard.2010.144782","article-title":"Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjogren\u2019s syndrome","volume":"70","author":"Theander","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.smim.2021.101547_bib0340","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/art.40528","article-title":"Ectopic germinal center-like structures in minor salivary gland biopsy tissue predict lymphoma occurrence in patients with primary Sjogren\u2019s syndrome","volume":"70","author":"Sene","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.smim.2021.101547_bib0345","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1136\/annrheumdis-2013-204634","article-title":"The prognostic value of routinely performed minor salivary gland assessments in primary Sjogren\u2019s syndrome","volume":"73","author":"Risselada","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.smim.2021.101547_bib0350","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.3899\/jrheum.131527","article-title":"Evaluation of germinal center-like structures and B cell clonality in patients with primary Sjogren syndrome with and without lymphoma","volume":"41","author":"Johnsen","year":"2014","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.smim.2021.101547_bib0355","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1136\/annrheumdis-2017-211290","article-title":"Germinal centres in diagnostic labial gland biopsies of patients with primary Sjogren\u2019s syndrome are not predictive for parotid MALT lymphoma development","volume":"76","author":"Haacke","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.smim.2021.101547_bib0360","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/art.21006","article-title":"Gene expression profiling of minor salivary glands clearly distinguishes primary Sjogren\u2019s syndrome patients from healthy control subjects","volume":"52","author":"Hjelmervik","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.smim.2021.101547_bib0365","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1002\/art.10445","article-title":"Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sjogren\u2019s syndrome","volume":"46","author":"Hansen","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.smim.2021.101547_bib0370","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3389\/fimmu.2013.00290","article-title":"Interferons in Sjogren\u2019s syndrome: genes, mechanisms, and effects","volume":"4","author":"Li","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2021.101547_bib0375","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1002\/art.30465","article-title":"Chitinases in the salivary glands and circulation of patients with Sjogren\u2019s syndrome: macrophage harbingers of disease severity","volume":"63","author":"Greenwell-Wild","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.smim.2021.101547_bib0380","doi-asserted-by":"crossref","first-page":"R238","DOI":"10.1186\/ar4081","article-title":"Systems analysis of primary Sjogren\u2019s syndrome pathogenesis in salivary glands identifies shared pathways in human and a mouse model","volume":"14","author":"Horvath","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.smim.2021.101547_bib0385","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1002\/art.22954","article-title":"Salivary proteomic and genomic biomarkers for primary Sjogren\u2019s syndrome","volume":"56","author":"Hu","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.smim.2021.101547_bib0390","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.humimm.2013.09.012","article-title":"Meta-analysis of differentially expressed genes in primary Sjogren\u2019s syndrome by using microarray","volume":"75","author":"Song","year":"2014","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.smim.2021.101547_bib0395","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9103299","article-title":"Transcriptomic profile of genes encoding proteins involved in pathogenesis of Sjogren\u2019s syndrome related xerostomia-molecular and clinical trial","volume":"9","author":"Blochowiak","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.smim.2021.101547_bib0400","article-title":"Transcriptomic and network analysis of minor salivary glands of patients with primary Sjogren\u2019s syndrome","volume":"11","author":"Oyelakin","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2021.101547_bib0405","doi-asserted-by":"crossref","first-page":"17368","DOI":"10.1002\/jcb.29001","article-title":"Identification of differentially expressed genes in primary Sjogren\u2019s syndrome","volume":"120","author":"Zhang","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.smim.2021.101547_bib0410","first-page":"777","article-title":"Laser microdissection coupled with RNA-seq reveal cell-type and disease-specific markers in the salivary gland of Sjogren\u2019s syndrome patients","volume":"35","author":"Tandon","year":"2017","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.smim.2021.101547_bib0415","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3389\/fimmu.2019.00795","article-title":"Elevated CCL19\/CCR7 expression during the disease process of primary Sjogren\u2019s syndrome","volume":"10","author":"Liu","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2021.101547_bib0420","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.706737","article-title":"NKp30 receptor upregulation in salivary glands of Sjogren\u2019s syndrome characterizes ectopic lymphoid structures and is restricted by rituximab treatment","volume":"12","author":"Pontarini","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2021.101547_bib0425","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.smim.2021.101547_bib0430","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1752-0509-2-95","article-title":"Integrated weighted gene co-expression network analysis with an application to chronic fatigue syndrome","volume":"2","author":"Presson","year":"2008","journal-title":"BMC Syst. Biol."},{"key":"10.1016\/j.smim.2021.101547_bib0435","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.3389\/fgene.2019.01142","article-title":"Identifying key genes and functionally enriched pathways in Sjogren\u2019s syndrome by weighted gene Co-expression network analysis","volume":"10","author":"Yao","year":"2019","journal-title":"Front. Genet."},{"key":"10.1016\/j.smim.2021.101547_bib0440","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13075-020-02248-2","article-title":"Identification of novel genes associated with dysregulation of B cells in patients with primary Sjogren\u2019s syndrome","volume":"22","author":"Inamo","year":"2020","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.smim.2021.101547_bib0445","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.592490","article-title":"Transcriptome sequencing reveals potential roles of ICOS in primary Sjogren\u2019s syndrome","volume":"8","author":"Luo","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.smim.2021.101547_bib0450","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.681941","article-title":"The transcriptome of paired major and minor salivary gland tissue in patients with primary Sjogren\u2019s syndrome","volume":"12","author":"Verstappen","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2021.101547_bib0455","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/art.30131","article-title":"MicroRNA expression profiles as biomarkers of minor salivary gland inflammation and dysfunction in Sjogren\u2019s syndrome","volume":"63","author":"Alevizos","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.smim.2021.101547_bib0460","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1093\/rheumatology\/keaa163","article-title":"Circular RNA sequencing indicates circ-IQGAP2 and circ-ZC3H6 as noninvasive biomarkers of primary Sjogren\u2019s syndrome","volume":"59","author":"Li","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.smim.2021.101547_bib0465","first-page":"1","article-title":"An update of targeted therapeutic options for primary Sjogren syndrome: current status and future development","author":"Retamozo","year":"2021","journal-title":"Expert Opin. Pharmacother."},{"issue":"Suppl 118","key":"10.1016\/j.smim.2021.101547_bib0470","first-page":"217","article-title":"B cell depletion with rituximab in the treatment of primary Sjogren\u2019s syndrome: what have we learnt?","volume":"37","author":"Grigoriadou","year":"2019","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.smim.2021.101547_bib0475","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2015-208304","article-title":"Towards personalised treatment in primary Sjogren\u2019s syndrome: baseline parotid histopathology predicts responsiveness to rituximab treatment","author":"Delli","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.smim.2021.101547_bib0480","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162787","article-title":"High-grade salivary-gland involvement, assessed by histology or ultrasonography, is associated with a poor response to a single rituximab course in primary Sjogren\u2019s syndrome: data from the TEARS randomized trial","volume":"11","author":"Cornec","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.smim.2021.101547_bib0485","doi-asserted-by":"crossref","first-page":"R172","DOI":"10.1186\/ar4359","article-title":"Efficacy and safety of rituximab treatment in early primary Sjogren\u2019s syndrome: a prospective, multi-center, follow-up study","volume":"15","author":"Carubbi","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.smim.2021.101547_bib0490","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jaut.2015.11.002","article-title":"Blood and salivary-gland BAFF-driven B-cell hyperactivity is associated to rituximab inefficacy in primary Sjogren\u2019s syndrome","volume":"67","author":"Cornec","year":"2016","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.smim.2021.101547_bib0495","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/art.22536","article-title":"Improvement of Sjogren\u2019s syndrome after two infusions of rituximab (anti-CD20)","volume":"57","author":"Devauchelle-Pensec","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.smim.2021.101547_bib0500","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/art.22603","article-title":"BAFF-modulated repopulation of B lymphocytes in the blood and salivary glands of rituximab-treated patients with Sjogren\u2019s syndrome","volume":"56","author":"Pers","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.smim.2021.101547_bib0505","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1002\/art.24903","article-title":"Clinical and histologic evidence of salivary gland restoration supports the efficacy of rituximab treatment in Sjogren\u2019s syndrome","volume":"60","author":"Pijpe","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.smim.2021.101547_bib0510","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jaut.2017.03.012","article-title":"FcRL4(+) B-cells in salivary glands of primary Sjogren\u2019s syndrome patients","volume":"81","author":"Haacke","year":"2017","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.smim.2021.101547_bib0515","article-title":"Efficacy and safety of abatacept in active primary Sjogren\u2019s syndrome: results of a phase III, randomised, placebo-controlled trial","author":"Baer","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.smim.2021.101547_bib0520","first-page":"11","article-title":"Abatacept treatment for patients with early active primary Sj\u00f6gren\u2019s syndrome: a single-centre, randomised, double-blind, placebo-controlled, phase 3 trial (ASAP-III study)","volume":"2","author":"J.F","year":"2020","journal-title":"Lancet Rheumatol."},{"key":"10.1016\/j.smim.2021.101547_bib0525","first-page":"317","article-title":"Abatacept treatment of patients with primary Sjogren\u2019s syndrome results in a decrease of germinal centres in salivary gland tissue","volume":"35","author":"Haacke","year":"2017","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.smim.2021.101547_bib0530","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1002\/art.40165","article-title":"Attenuation of follicular helper T cell-dependent B cell hyperactivity by abatacept treatment in primary Sjogren\u2019s syndrome","volume":"69","author":"Verstappen","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.smim.2021.101547_bib0535","first-page":"11","article-title":"Assessment of the anti-CD40 antibody iscalimab in patients with primary Sj\u00f6gren\u2019s syndrome: a multicentre, randomised, double-blind, placebo-controlled, proof-of-concept study","volume":"2","author":"Fisher","year":"2020","journal-title":"Lancet Rheumatol."},{"key":"10.1016\/j.smim.2021.101547_bib0540","first-page":"2","article-title":"A phase 2a study of MEDI5872 (AMG557), a fully human Anti-ICOS ligand monoclonal antibody in patients with primary sj\u00f6gren\u2019s syndrome","volume":"71","author":"Mariette","year":"2019","journal-title":"Arthritis Rheumatol."},{"issue":"Suppl 126","key":"10.1016\/j.smim.2021.101547_bib0545","first-page":"180","article-title":"The use of digital image analysis in the histological assessment of Sjogren\u2019s syndrome salivary glands improves inter-rater agreement and facilitates multicentre data harmonisation","volume":"38","author":"Lucchesi","year":"2020","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.smim.2021.101547_bib0550","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1136\/annrheumdis-2016-210448","article-title":"Standardisation of labial salivary gland histopathology in clinical trials in primary Sjogren\u2019s syndrome","volume":"76","author":"Fisher","year":"2017","journal-title":"Ann. Rheum. Dis."}],"container-title":["Seminars in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532321000786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532321000786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T23:21:45Z","timestamp":1760916105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044532321000786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":110,"alternative-id":["S1044532321000786"],"URL":"https:\/\/doi.org\/10.1016\/j.smim.2021.101547","relation":{},"ISSN":["1044-5323"],"issn-type":[{"value":"1044-5323","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cellular and molecular diversity in Sjogren\u2019s syndrome salivary glands: Towards a better definition of disease subsets","name":"articletitle","label":"Article Title"},{"value":"Seminars in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.smim.2021.101547","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101547"}}